Last reviewed · How we verify

NCT03741803

Relationship Between Delayed Cord Clamping at Birth and Neonatal Bilirubin Levels in Parturients With a Prior Child Requiring Therapy for Neonatal Jaundice

Completed NA Last updated 18 March 2026
What this trial tests

NA trial testing Delayed cord clamping in Hyperbilirubinemia, Neonatal in 20 participants. Completed in 27 May 2019.

Timeline
9 November 2018
Primary endpoint
27 May 2019
27 May 2019

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment20
Start date9 November 2018
Primary completion27 May 2019
Estimated completion27 May 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 18 to 40, female only, with Hyperbilirubinemia, Neonatal or Jaundice, Neonatal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to determine if neonates (who already have an increased risk of hyperbilirubinemia due to mother's history of having previous neonate who received phototherapy for hyperbilirubinemia) have higher bilirubin levels 24 hours after birth with delayed cord clamping.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Delayed cord clamping

Trials testing the same drug.

Other recruiting trials for Hyperbilirubinemia, Neonatal

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03741803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing